These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5772752)

  • 1. Studies on the metabolism of diphenylhydantoin in mice.
    Gerber N; Arnold K
    J Pharmacol Exp Ther; 1969 May; 167(1):77-90. PubMed ID: 5772752
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of diphenyl-piperazine compounds and other agents on diphenylhydantoin, zoxazolamine and hexobarbital metabolism.
    Gerber N; Arnold K
    J Pharmacol Exp Ther; 1968 Nov; 164(1):232-8. PubMed ID: 4387047
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.
    Robinson JR; Nebert DW
    Mol Pharmacol; 1974 May; 10(3):484-93. PubMed ID: 4852151
    [No Abstract]   [Full Text] [Related]  

  • 4. 5,5'-Diphenyl-2-thiohydantoin (DPTH): an inducer of microsomal drug-metabolizing enzymes.
    Dalton C; Kamm JJ; Bartl P
    J Pharmacol Exp Ther; 1972 Sep; 182(3):491-9. PubMed ID: 5055407
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats.
    Kemp JW; Tannhauser M; Swinyard EA
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):37-47. PubMed ID: 5111324
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of hepatic drug metabolism in rats by methylchloroform inhalation.
    Fuller GC; Olshan A; Puri SK; Lal H
    J Pharmacol Exp Ther; 1970 Nov; 175(2):311-7. PubMed ID: 4394799
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on the stimulation of L-(14C)-amino acid incorporation with cycloheximide.
    Jondorf WR; Simon DC; Avnimelech M
    Mol Pharmacol; 1966 Nov; 2(6):506-17. PubMed ID: 5965319
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms in the potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol.
    Yasaka WJ; Sasame HA; Saul W; Maling HM; Gillette JR
    Biochem Pharmacol; 1978; 27(24):2851-8. PubMed ID: 736977
    [No Abstract]   [Full Text] [Related]  

  • 13. Diphenylhydantoin effect on neonatal and adult rat hepatic drug metabolism.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    J Pharmacol Exp Ther; 1970 Jan; 171(1):127-34. PubMed ID: 5410930
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of DDT and gamma-chlordane on the metabolism of hexobarbital and zoxazolamine in 2 mouse strains.
    Cram RL; Fouts JR
    Biochem Pharmacol; 1967 Jun; 16(6):1001-6. PubMed ID: 6040382
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on drug metabolism and hepatic microsomes of rats and mice.
    Greig JB; De Matteis F
    Environ Health Perspect; 1973 Sep; 5():211-9. PubMed ID: 4752904
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lipid A content, hydrocortisone and polymyxin B on endotoxin-induced decreases in in vivo drug metabolism.
    Abernathy CO; Zimmerman HJ; Utili R
    Microbios; 1987; 49(199):91-6. PubMed ID: 3033452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of benzo[a]pyrene derivatives upon drug metabolising enzyme activities.
    Dewhurst F; Kitchen DA
    Biochem Pharmacol; 1969 Apr; 18(4):942-5. PubMed ID: 5788536
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of microsomal drug metabolism by methylenedioxybenzenes.
    Anders MW
    Biochem Pharmacol; 1968 Nov; 17(11):2367-70. PubMed ID: 5718145
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.